Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 354, Issue 1386, 1999, Pages 981-989

  Cha, Jang Ho J ^a   Frey, Ariel S ^a   Alsdorf, Stephen A ^a   Kerner, Julie A ^a   Kosinski, Christoph M ^a   Mangiarini, Laura ^b   Penney Jr , John B ^a   Davies, Stephen W ^c   Bates, Gillian P ^b   Young, Anne B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glutamate; Huntington's disease; Hybridization in situ; Receptor; Striatum; Transgenic mouse

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADENOSINE; DISEASE MODEL; DOPAMINE; GENETIC TRANSCRIPTION; GLUTAMIC ACID; HUNTINGTON CHOREA; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER RECEPTOR; PATHOGENESIS; PHENOTYPE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0033614761     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1999.0449     Document Type: Article

References (47)

1. Albin, R. L. & Greenamyre, J. T. 1992 Alternative excitotoxic hypotheses. Neurology 42, 733-738.
2. Albin, R. L., Young, A. B., Penney, J. B., Handelin, B., Balfour, R., Anderson, K. D., Markel, D. S., Tourtellotte, W. W. & Reiner, A. 1990 Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. New Engl. J. Med. 322, 1293-1298.
3. 2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 119, 2085-2095.
4. Augood, S. J., Faull, R. L. M., Love, D. R. & Emson, P. C. 1996 Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 72, 1023-1036.
5. 2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol. 42, 215-221.
6. Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J. & Martin, J. B. 1986 Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-171.
7. Bertaux, F., Sharp, A. H., Ross, C. A., Lehrach, H., Bates, G. P. & Wanker, E. 1998 HAP1 huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice. FEBS Lett. 426, 229-232.
8. 3H]glutamate binding sites. NeuroReport 4, 311-313.
9. 3H]Glutamate labels the metabotropic excitatory amino acid receptor in rodent brain. Neurosci. Lett. 113, 78-83.
10. Cha, J.-H. J., Makowiec, R. L., Penney, J. B. & Young, A. B. 1992 Multiple states of rat brain (RS)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography. Mol. Pharmacol. 41, 832-838.
11. Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P. & Young, A. B. 1998 Altered brain neurotransmitter receptors in trangenic mice expressing a portion of an abnormal human Huntington disease gene. Proc. Natl Acad. Sci. USA 95, 6480-6485.
12. B binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience 34, 341-357.
13. 3H]YM-09151-2. Eur. J. Pharmacol. 199, 103-106.
14. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L. & Bates, G. P. 1997 Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
15. Davies, S. W., Beardsall, K., Turmaine, M., DiFiglia, M., Aronin, N. & Bates, G. P. 1998 Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 351, 131-133.
16. de la Monte, S. M., Vonsattel, J.-P. & Richardson Jr, E. P. 1988 Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 47, 516-525.
17. DiFiglia, M. 1990 Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13, 286-289.
18. DiFiglia, M. (and 11 others) 1995 Huntingtin is a cytoplasmic protein asociated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
19. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S.W., Bates, G. P., Vonsattel, J. P. & Aronin, N. 1997 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
20. Dure IV, L. S., Young, A. B. & Penney, J. B. 1991 Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease. Ann. Neurol. 30, 785-793.
21. A-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid lesioned rat. Prog. Brain Res. 99, 105-123.
22. Greenamyre, J. T., Olson, J. M. M., Penney, J. B. & Young, A. B. 1985 Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate-and kainate-sensitive glutamate binding sites. J. Pharmacol. Exp. Ther. 233, 254-263.
23. Huntington's Disease Collaborative Research Group 1993 A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes. Cell 72, 971-983.
24. 3H-CGS21680. Eur. J. Pharmacol. 168, 243-246.
25. 3H]Mazindol binding associated with neuronal dopamine uptake sites in corpus stratum membranes. Eur. J. Pharmacol. 90, 461-462.
26. Lansbury Jr, P. T. 1997 Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19, 1151-1154.
27. London, E. D., Yamamura, H. I., Bird, E. D. & Coyle, J. T. 1981 Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. Biol. Psychiat. 16, 155-162.
28. Mangiarini, L. (and 10 others) 1996 Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
29. Martinez-Mir, M. I., Probst, A. & Palacios, J. M. 1991 Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 42, 697-706.
30. Paulson, H. L. & Fischbeck, K. H. 1996 Trinucleotide repeats in neurogenetic disorders. A. Rev. Neurosci. 19, 79-107.
31. Penney, J. B. & Young, A. B. 1982 Quantitative autoradiography of neurotransmitter receptors in Huntington's disease. Neurology 32, 1391-1395.
32. Perutz, M. F. 1996 Glutamine repeats and inherited neurode-generative diseases: molecular aspects. Curr. Opin. Struct. Biol. 6, 848-858.
33. Perutz, M. F., Johnson, T., Suzuki, M. & Finch, J. T. 1994 Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl Acad. Sci. USA 91, 5355-5358.
34. Reddy, R. S. & Housman, D. E. 1997 The complex pathology of trinucleotide repeats. Curr. Opin. Cell Biol. 9, 364-372.
35. Reisine, T. D., Fields, J. Z., Stern, L. Z., Johnson, P. C., Bird, E. D. & Yamamura, H. I. 1977 Alterations in dopaminergic receptors in Huntington's disease. Life Sci. 21, 1123-1128.
36. 2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections. Brain Res. 383, 121-128.
37. Richfield, E. K., O'Brien, C. F., Eskin, T. & Shoulson, I. 1991 Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neurosci. Lett. 132, 121-126.
38. Roizin, L., Stellar, S. & Liu, J. C. 1979 Neuronal nuclear cytoplasmic changes in Huntington's chorea: electron microscope investigations. In Advances in neurology, vol. 23 (ed. T. N. Chase, N. S. Wexler & A. Barbeau), pp. 95-122. New York: Raven Press.
39. Ross, C. A. 1997 Intranuclear neuronal inclusions: a common mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
40. Sapp, E., Schwarz, C., Chase, K., Bhide, P. G., Young, A. B., Penney, J., Vonsattel, J. P., Aronin, N. & DiFiglia, M. 1997 Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42, 604-612.
41. Standaert, D. G., Landwehrmeyer, G. B., Kerner, J. A., Penney Jr, J. B. & Young, A. B. 1996 Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex, and hippocampus. Mol. Brain Res. 42, 89-102.
42. Van Ness, P. C., Watkins, A. E., Bergman, M. O., Tourtellotte, W. W. & Olsen, R. W. 1982 γ-aminobutyric acid receptors in normal human brain and Huntington disease. Neurology 32, 63-68.
43. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D. & Richardson, E. P. 1985 Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
44. Walker, F. O., Young, A. B., Penney, J. B., Dorovini-Zis, K. & Shoulson, I. 1984 Benzodiazepine receptors in early Huntington's disease. Neurology 34, 1237-1240.
45. 2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann. Neurol. 40, 49-54.
46. Wüllner, U., Standaert, D. G., Testa, C. M., Landwehrmeyer, G. B., Catania, M. V., Penney Jr, J. B. & Young, A. B. 1994 Glutamate receptor expression in rat striatum: effect of deafferentation. Brain Res. 647, 209-219.
47. Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I. & Penney, J. B. 1988 NMDA receptor losses in putamen from patients with Huntington's disease. Science 241, 981-983.